fashion -WSS

fashion

author：knowledge 2025-10-01 18:23:08 - browse：39

Medicare is planning to send $9 billion in lump sum payments to more than 1,600 hospitals that participate in a drug discount program. Adobe

WASHINGTON — Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in a drug discount program after the Supreme Court found the program underpaid them for prescription drugs, the agency announced on Friday.

To pay for the restitution, Medicare would slash all hospitals’ payments for other items and services by 0.5% for the next 16 years.

The remedy accounts for four years of underpayments to hospitals that participate in the 340B drug discount program. The Trump administration dramatically reduced Medicare payments for discounted drugs in 2018, but the Supreme Court found they didn’t follow the proper procedure and that the payment scheme was illegal.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： ASCO: Palliative care found as helpful given virtually as in person

hotspot

WSS

FDA's Pazdur wants cancer trials to range beyond China alone

In same hospitals, Black patients receive fewer opioids than white patients

Wegovy’s successful heart trial raises vital question about weight loss

Man killed during FBI raid in connection with threats against Biden, other officials

Anavex keeps shifting the goalposts in its clinical trials

Shifting the focus from loneliness to social health

leisure time

fashion

focus

Apple is now the first public company to be valued at $3 trillion

Shifting the focus from loneliness to social health

As demand for Covid shots wanes, Moderna seeks its next success

HIV drugs protect against transmission, even in unprotected sex

Heart attack and stroke risk calculators need revising

FDA panel issues narrow recommendation for Covid vaccine booster doses

George Santos makes 1st court appearance after pleading not guilty to 13 counts

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Change Healthcare can notify patients about the breach, HHS says

knowledge

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Friends ask where James Watson's attitudes about race came from

ASCO: AstraZeneca says CAR

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Intellia reports positive results for its CRISPR

At ASCO, AstraZeneca reports strong data for breast cancer drug

hotspot

explore

hotspot

focus